Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lawton LN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
IScience [iScience] 2024 Jul 02; Vol. 27 (7), pp. 110386. Date of Electronic Publication: 2024 Jul 02 (Print Publication: 2024).
Autor:
Yan Q; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ding J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Khan SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Publikováno v:
IScience [iScience] 2023 Mar 17; Vol. 26 (4), pp. 106444. Date of Electronic Publication: 2023 Mar 17 (Print Publication: 2023).
Autor:
Kanouni T; Fount Therapeutics, LLC, San Diego, California 92130, United States., Severin C; Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States., Cho RW; Quanticel Pharmaceuticels, San Francisco, California 94158, United States., Yuen NY; Oric Pharmaceuticals, South San Francisco, California 94080, United States., Xu J; Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States., Shi L; Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States., Lai C; Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States., Del Rosario JR; Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States., Stansfield RK; 858 Therapeutics, Inc., San Diego, California 92121, United States., Lawton LN; Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Hosfield D; University of Chicago, Chicago, Illinois 60637, United States., O'Connell S; Pfizer Inc., San Diego, California 92121, United States., Kreilein MM; Bristol Myers Squibb, Summit, New Jersey 07901, United States., Tavares-Greco P; Bristol Myers Squibb, Summit, New Jersey 07901, United States., Nie Z; Schrödinger, Inc., San Diego, California 92121, United States., Kaldor SW; Fount Therapeutics, LLC, San Diego, California 92130, United States., Veal JM; 858 Therapeutics, Inc., San Diego, California 92121, United States., Stafford JA; 858 Therapeutics, Inc., San Diego, California 92121, United States., Chen YK; Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Dec 10; Vol. 63 (23), pp. 14522-14529. Date of Electronic Publication: 2020 Oct 09.
Autor:
Cader FZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; AstraZeneca, City House, Cambridge, UK., Hu X; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; GV20 Therapeutics LLC, Cambridge, MA, USA., Goh WL; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Wienand K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Hematology and Oncology, Göttingen Comprehensive Cancer Center, Göttingen, Germany., Ouyang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mandato E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Redd R; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen PH; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schackmann RCJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Merus, Utrecht, the Netherlands., Li B; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA., Ma W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Clarion Healthcare, Boston, MA, USA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Liu XS; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. xsliu@ds.dfci.harvard.edu.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. xsliu@ds.dfci.harvard.edu., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Margaret_Shipp@dfci.harvard.edu.
Publikováno v:
Nature medicine [Nat Med] 2020 Sep; Vol. 26 (9), pp. 1468-1479. Date of Electronic Publication: 2020 Aug 10.
Autor:
Chen L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Current address: H3 Biomedicine, Cambridge, MA, USA., Ouyang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wienand K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bojarczuk K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Current address: Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Hao Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Current Address: Department of Pathology, Mount Sinai Hospital, New York, NY, USA., Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Current Address: Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Neuberg D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA., Juszczynski P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Current address: Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Monti S; Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA margaret_shipp@dfci.harvard.edu.
Publikováno v:
Haematologica [Haematologica] 2020 May; Vol. 105 (5), pp. 1361-1368. Date of Electronic Publication: 2019 Aug 30.
Autor:
Wienand K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Stewart C; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA., Dunford AJ; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA., Wu D; Department of Laboratory Medicine, University of Washington, Seattle, WA., Kim J; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA., Kamburov A; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA., Wood TR; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA., Cader FZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Ducar MD; Department of Data Science, Knowledge Systems Group, Boston, MA.; Center for Cancer Genome Discovery, Boston, MA., Thorner AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Cancer Genome Discovery, Boston, MA., Nag A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Cancer Genome Discovery, Boston, MA., Heubeck AT; Hematologic Neoplasia Flow Cytometry Core and., Buonopane MJ; Hematologic Neoplasia Flow Cytometry Core and., Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Bojarczuk K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA; and., Fromm JR; Department of Laboratory Medicine, University of Washington, Seattle, WA., Getz G; Harvard Medical School, Boston, MA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA.; Department of Pathology and.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2019 Dec 10; Vol. 3 (23), pp. 4065-4080.
Autor:
Wang L; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore., Tan TK; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Durbin AD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02216, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02215, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Zimmerman MW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02216, USA., Abraham BJ; Whitehead Institute for Biomedical Research, Cambridge, MA, 02142, USA.; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38102, USA., Tan SH; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Ngoc PCT; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Weichert-Leahey N; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02216, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02215, USA., Akahane K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02216, USA.; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, 4093898, Japan., Lawton LN; Whitehead Institute for Biomedical Research, Cambridge, MA, 02142, USA., Rokita JL; Oncology Division, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA., Maris JM; Oncology Division, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, 19104, USA., Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA, 02142, USA.; Biology Department, MIT, Cambridge, MA, 02142, USA., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02216, USA. thomas_look@dfci.harvard.edu.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02215, USA. thomas_look@dfci.harvard.edu., Sanda T; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. takaomi_sanda@nus.edu.sg.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore. takaomi_sanda@nus.edu.sg.
Publikováno v:
Nature communications [Nat Commun] 2019 Dec 09; Vol. 10 (1), pp. 5622. Date of Electronic Publication: 2019 Dec 09.
Autor:
Bojarczuk K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Wienand K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Chen L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Villalobos-Ortiz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Mandato E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Stachura J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
Publikováno v:
Blood [Blood] 2019 Jan 03; Vol. 133 (1), pp. 70-80. Date of Electronic Publication: 2018 Oct 15.
Autor:
Leong WZ; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Tan SH; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Ngoc PCT; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Amanda S; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Yam AWY; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Liau WS; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Gong Z; Department of Biological Sciences, National University of Singapore, 117543 Singapore., Lawton LN; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Tenen DG; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore.; Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 117599 Singapore., Sanda T; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 117599 Singapore.
Publikováno v:
Genes & development [Genes Dev] 2017 Dec 01; Vol. 31 (23-24), pp. 2343-2360. Date of Electronic Publication: 2018 Jan 11.